Heterocyclic inhibitors of glycogen synthase kinase GSK-3

Details for Australian Patent Application No. 2006200668 (hide)

Owner Consejo Superior de Investigaciones Cientificas

Inventors Wandosell Jurado, Francisco; Martinez Gil, Ana; Perez Martin, Maria Concepcion; Diaz, Isabel Dorronsoro; Cascon, Mercedes Alonso; Castro Morera, Ana; Moreno Munoz, Francisco Jose

Agent Griffith Hack

Pub. Number AU-B-2006200668

Parent 783615

Filing date 17 February 2006

Wipo publication date 16 March 2006

Acceptance publication date 18 October 2007

International Classifications

C07D 207/44 (2006.01) Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

A61K 31/122 (2006.01) - having the oxygen atom directly attached to a ring, e.g. quinones, vitamin K, anthralin

A61K 31/4015 (2006.01) - having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide

A61K 31/4035 (2006.01)

A61K 31/4196 (2006.01) - 1,2,4-Triazoles

A61K 31/426 (2006.01) - 1,3-Thiazoles

A61K 31/433 (2006.01) - Thiadiazoles

A61K 31/4439 (2006.01)

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61P 17/06 (2006.01) Drugs for dermatological disorders

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

A61P 31/00 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 35/00 (2006.01) Antineoplastic agents

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07C 49/395 (2006.01) Ketones

C07C 49/597 (2006.01) Ketones

C07D 207/448 (2006.01) Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 207/456 (2006.01) Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 209/48 (2006.01) Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 249/12 (2006.01) Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms

C07D 277/20 (2006.01) Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

C07D 277/36 (2006.01) Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

Event Publications

9 March 2006 Complete Application Filed

16 March 2006 Application Open to Public Inspection

  Published as AU-B-2006200668

18 October 2007 Application Accepted

  Published as AU-B-2006200668

14 February 2008 Standard Patent Sealed

19 February 2009 Assignment Registered

  Consejo Superior de Investigaciones Cientificas The patent has been assigned to Consejo Superior de Investigaciones Cientificas; Universidad Autonoma de Madrid

4 June 2009 Licence Registered

  Universidad Autonoma de Madrid; Consejo Superior de Investigaciones Cientificas ( Neuropharma S.A. )

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006200669-Claudin polypeptides

2006200667-A reinforcing component